NCT00531583
Completed
Not Applicable
Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor
ConditionsLeukemia, Monocytic, Acute
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Leukemia, Monocytic, Acute
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Enrollment
- 350
- Locations
- 1
- Primary Endpoint
- Efficacy
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantation program for pts w/AML in 1st & 2nd complete remission w/no HLA matched related donor
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with AML in 1st \& 2nd complete remission w/no HLA matched related donor
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Efficacy
Time Frame: 2009-2015
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)JPRN-UMIN000026084agoya University Graduate School of Medicine10
Completed
Not Applicable
Autologous peripheral blood stem cell transplantation as consolidation for high risk diffuse large B-cell lymphoma:A phase II studyDiffuse Large B-Cell Lymphoma:IPI high risk group, CR1JPRN-UMIN000012546ishiwaki Municipal Hospital18
Recruiting
Not Applicable
Autologous peripheral blood stem cell transplantation for elderly patients (65-74 years old) with multiple myeloma.multiple myelomaJPRN-UMIN000038905Tokyo-Kita Medical Center20
Completed
Phase 2
Autologous peripheral blood stem cell transplantation using MEAM regimen with HAART for refractory and relapsed HIV associated lymphoma: multicentered phase2 clinical trialRefractory and relapsed HIV associated lymphomaJPRN-UMIN000003159Research fund of Ministry Health, Labour and Welfare for a counter measure against AIDS, Okada group and Tanabe group18
Completed
Phase 2
Peripheral Stem Cell Transplant in Treating Patients With Multiple MyelomaMultiple MyelomaPlasma Cell NeoplasmNCT00028600Alliance for Clinical Trials in Oncology60